In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more
8/25/2025
/ Artificial Intelligence ,
Clinical Trials ,
Cybersecurity ,
Digital Health ,
Environmental Social & Governance (ESG) ,
Genetic Materials ,
Government Agencies ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Life Sciences ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Supply Chain ,
Trump Administration
Since his inauguration in January, President Trump has signed multiple executive orders addressing diversity, equity, and inclusion (DEI) policies across the country. These actions have significant implications, including for...more
Please join us on November 5 for a dynamic CLE discussion to navigate internal investigations across the media and entertainment industries. The program will keep you engaged with perspectives from across our Labor &...more
11/3/2021
/ Anti-Bribery ,
Anti-Corruption ,
Attorney-Client Privilege ,
Compliance ,
Continuing Legal Education ,
Enforcement ,
Entertainment Industry ,
Environmental Social & Governance (ESG) ,
Internal Investigations ,
Popular ,
Webinars